These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1177 related items for PubMed ID: 23267787

  • 1. Effect of rapamycin and interleukin-2 on regulatory CD4+CD25+Foxp3+ T cells in mice after allogenic corneal transplantation.
    Wang X, Wang W, Xu J, Le Q.
    Transplant Proc; 2013 Mar; 45(2):528-37. PubMed ID: 23267787
    [Abstract] [Full Text] [Related]

  • 2. Pretreatment of rapamycin before allogenic corneal transplant promotes graft survival through increasing CD4(+)CD25(+)Foxp3(+) regulatory T cells.
    Wang X, Wang W, Xu J, Hong J, Le Q.
    Exp Clin Transplant; 2013 Feb; 11(1):56-62. PubMed ID: 22769982
    [Abstract] [Full Text] [Related]

  • 3. Rapamycin combined with allogenic immature dendritic cells selectively expands CD4+CD25+Foxp3+ regulatory T cells in rats.
    Wang GY, Zhang Q, Yang Y, Chen WJ, Liu W, Jiang N, Chen GH.
    Hepatobiliary Pancreat Dis Int; 2012 Apr; 11(2):203-8. PubMed ID: 22484590
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice.
    Qu Y, Zhang B, Zhao L, Liu G, Ma H, Rao E, Zeng C, Zhao Y.
    Transpl Immunol; 2007 Apr; 17(3):153-61. PubMed ID: 17331841
    [Abstract] [Full Text] [Related]

  • 6. CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(-) naive T cells display more potent regulatory ability in vitro.
    Chen JF, Gao J, Zhang D, Wang ZH, Zhu JY.
    Chin Med J (Engl); 2010 Apr 05; 123(7):942-8. PubMed ID: 20497692
    [Abstract] [Full Text] [Related]

  • 7. [Effect of Rapamycin on CD4(+) CD25(+) regulatory T cells in allo-transplantation tolerance model].
    Zheng YX, Hou GH, Song J, Zhang C, Liang T.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Apr 05; 23(4):327-30. PubMed ID: 17428387
    [Abstract] [Full Text] [Related]

  • 8. In vitro-expanded CD4(+)CD25(high)Foxp3(+) regulatory T cells controls corneal allograft rejection.
    Guo X, Jie Y, Ren D, Zeng H, Zhang Y, He Y, Pan Z.
    Hum Immunol; 2012 Nov 05; 73(11):1061-7. PubMed ID: 22939904
    [Abstract] [Full Text] [Related]

  • 9. Rapamycin, unlike cyclosporine A, enhances suppressive functions of in vitro-induced CD4+CD25+ Tregs.
    Bocian K, Borysowski J, Wierzbicki P, Wyzgal J, Klosowska D, Bialoszewska A, Paczek L, Górski A, Korczak-Kowalska G.
    Nephrol Dial Transplant; 2010 Mar 05; 25(3):710-7. PubMed ID: 19903662
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Combined therapy of CD4(+)CD25(+) regulatory T cells with low-dose sirolimus, but not calcineurin inhibitors, preserves suppressive function of regulatory T cells and prolongs allograft survival in mice.
    Ma A, Qi S, Wang Z, Massicotte E, Dupuis M, Daloze P, Chen H.
    Int Immunopharmacol; 2009 May 05; 9(5):553-63. PubMed ID: 19539558
    [Abstract] [Full Text] [Related]

  • 13. Expansion of CD4(+)CD25 (+) regulatory T cells from cord blood CD4(+) cells using the common γ-chain cytokines (IL-2 and IL-15) and rapamycin.
    Asanuma S, Tanaka J, Sugita J, Kosugi M, Shiratori S, Wakasa K, Shono Y, Shigematsu A, Kondo T, Kobayashi T, Asaka M, Imamura M.
    Ann Hematol; 2011 Jun 05; 90(6):617-24. PubMed ID: 21107839
    [Abstract] [Full Text] [Related]

  • 14. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
    Wang DW, Zhou RB, Yao YM, Zhu XM, Yin YM, Zhao GJ, Dong N, Sheng ZY.
    J Pharmacol Exp Ther; 2010 Dec 05; 335(3):553-61. PubMed ID: 20843956
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. In Vivo Expansion of Regulatory T Cells by Low-Dose Interleukin-2 Treatment Increases Allograft Survival in Corneal Transplantation.
    Tahvildari M, Omoto M, Chen Y, Emami-Naeini P, Inomata T, Dohlman TH, Kaye AE, Chauhan SK, Dana R.
    Transplantation; 2016 Mar 05; 100(3):525-32. PubMed ID: 26881788
    [Abstract] [Full Text] [Related]

  • 17. Costimulation blockade-induced cardiac allograft tolerance: inhibition of T cell expansion and accumulation of intragraft cD4(+)Foxp3(+) T cells.
    Oderup C, Malm H, Ekberg H, Qi Z, Veress B, Ivars F, Corbascio M.
    Transplantation; 2006 Dec 15; 82(11):1493-500. PubMed ID: 17164722
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
    Tian B, Hao J, Zhang Y, Tian L, Yi H, O'Brien TD, Sutherland DE, Hering BJ, Guo Z.
    Transplantation; 2009 Jan 27; 87(2):198-206. PubMed ID: 19155973
    [Abstract] [Full Text] [Related]

  • 20. Systemic application of sphingosine 1-phosphate receptor 1 immunomodulator inhibits corneal allograft rejection in mice.
    Zhu J, Liu Y, Pi Y, Jia L, Wang L, Huang Y.
    Acta Ophthalmol; 2014 Feb 27; 92(1):e12-21. PubMed ID: 23910624
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.